Results 21 to 30 of about 46,848 (253)

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials

BMC Psychiatry, 2007
Background Atypical antipsychotics are increasingly used for treatment of mental illnesses like schizophrenia and bipolar disorder, and considered to have fewer extrapyramidal effects than older antipsychotics.
Moore R Andrew, Derry Sheena
doaj   +1 more source

Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil [PDF]

, 2018
Background: Schizophrenia is associated with significant economic burden. In Brazil, antipsychotics drugs, outpatient and hospital services are provided by the Brazilian National Health System for patients with schizophrenia.
Acurcio, Francisco de Assis, Barbosa, Wallace Breno, Barbui, Corrado, Bennie, Marion, Costa, Juliana de Oliveira, de Oliveira, Helian Nunes, Godman, Brian, Gomes, Rosangela Maria, Jr, Guerra Augusto Afonso, Pires de Lemos, Livia Lovato, Ruas, Cristina Mariano   +10 more
core   +2 more sources

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia [PDF]

, 2006
Background There is an ongoing debate over whether atypical antipsychotics are more effective than typical antipsychotics in the treatment of schizophrenia.
Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, Ron Landbloom, Marvin Swartz, Jeff Swanson, MI Herz, PJ Weiden, R Mojtabai, BL Svarstad, P Thieda, JA Cramer, J Geddes, JM Davis, M Chakos, S Leucht, R Rosenheck, RA Rosenheck, JA Lieberman, AF Lehman, DS Salkever, JW Swanson, H Ascher-Svanum, D Faries, HA Huskamp, PJ Gibson, TW Croghan, RB D'Agostino, B Zhu, JP Lacro, Y Hochberg, M Valenstein, H Liu-Seifert, E Dunayevich, J Haro, M Dossenbach, M Dossenbach, AB Jaffe, GW Hugenholtz, K Wahlbeck, S Leucht, KA Weiss, GD Tollefson, I Bitter, J Tiihonen, H Ascher-Svanum, VL Stauffer, Z Zhao, KL Rascati   +48 more
core   +2 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome with Rhabdomyolysis: A Case Report [PDF]

Endocrinology and Metabolism, 2013
Atypical antipsychotics have replaced conventional antipsychotics in the treatment of schizophrenia because they have less of a propensity to cause undesirable neurologic adverse events including extrapyramidal symptoms, tardive dyskinesia, and ...
Young Kyoung Sa, Hyeon Yang, Hee Kyoung Jung, Jang Won Son, Seong Su Lee, Seong Rae Kim, Bong Yeon Cha, Ho Young Son, Chi-Un Pae, Soon Jib Yoo   +9 more
doaj   +1 more source

Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study. [PDF]

, 2017
ObjectiveParkinson's disease psychosis (PDP) is a frequent complication of idiopathic Parkinson's disease (iPD) with significant impact on quality of life and association with poorer outcomes.
Bizzarri, Cummings, Fernandez, Fernandez, Fénelon, Gama, Goldman, Hack, Hubbard, Kiferle, Lertxundi, McFarland, Meltzer, Meral, Mesquita, Mocci, Munhoz, Noel, Pagonabarraga, Prohorov, Rabey, Reichmann, Rolland, Seppi, Shotbolt, Starkstein, Thomas, Vanover, Weintraub, Zhu   +29 more
core   +2 more sources

Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics [PDF]

, 2013
There is a critical need for mapping early metabolic changes in schizophrenia to capture failures in regulation of biochemical pathways and networks.
AA Farooqui, AI Glen, BE Leonard, C Luo, D Cohen, DF Horrobin, DF Horrobin, DP Rice, George G. Dougherty, GP Amminger, Henry A. Nasrallah, HM Rhoades, Hongjie Zhu, Jeffrey K. Yao, JJ Potwarka, JK Yao, JK Yao, JM Kane, Joseph McEvoy, JP McEvoy, JR Hibbeln, K Ohara, KS Dervola, M Arvindakshan, M McSweeney, M Peet, M Strassnig, M Zeman, Matcheri S. Keshavan, MK Gregory, MS Keshavan, MS Keshavan, MS Keshavan, Peter Buckley, R Kaddurah-Daouk, R Kaddurah-Daouk, RA Johnson, RD McQuade, Rebecca A. Baillie, Rima Kaddurah-Daouk, S Mukherjee, S Saddichha, S Sengupta, SH Fatemi, SJ Wood, SM Watkins, SM Watkins, SP Mahadik, T Sumiyoshi, Takeo Yoshikawa, TJ Barrett, TM du Bois, WJ van der Kemp, WP Hoen, Y Benjamini, Y Benjamini, YA Hannun   +56 more
core   +8 more sources

Serum paraoxonase levels of schizophrenia patients treated with typical, atypical and combined antipsychotics

Psychiatry and Clinical Psychopharmacology, 2021
Objective: Schizophrenia is a devastating disorder, starting in early adulthood and continuing with relapses and remissions. Prevalence of schizophrenia is 1% and the life expectancy of these patients is reduced.
Mehmet Akif Camkurt, Mehmet Gunes, Süleyman Demir, Aslihan İbiloglu, Mehmet Cemal Kaya, Mahmut Bulut, Abdullah Atli   +6 more
doaj  

The Effects of Atypical Antipsychotic Usage Duration on Serum Adiponectin Levels and Other Metabolic Parameters

Eurasian Journal of Medicine, 2019
Objective: Although atypical antipsychotics are well-tolerated and effective treatment options for schizophrenia, they have metabolic side effects, including weight gain and increased risk of Type II Diabetes Mellitus (DM).
Elif Oral, Mustafa Gulec, Nezahat Kurt, Sumeyra Yilmaz, Nazan Aydin, Ismet Kirpinar   +5 more
doaj   +1 more source

Patterns of management of patients with dual disorder (psychosis) in Italy: a survey of psychiatrists and other physicians focusing on clinical practice [PDF]

, 2018
© 2018 Clerici, de Bartolomeis, De Filippis, Ducci, Maremmani, Martinotti and Schifano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).Patients with severe psychotic disorders such as ...
Acquas, Akiskal, Archie, Bacopoulos, Blum, Blum, Bowirrat, Carra, Connelly, Cuomo, De Bartolomeis, De Bartolomeis, Degenhardt, Delisi, Fantini, Fiorillo, Getzen, Gouzoulis-Mayfrank, Grob, Hertzog, Howes, Iasevoli, Kerner, Lambert, Maremmani, Martin, Martinotti, Nesvag, Ostuzzi, Papageorgiou, Regier, Roncero, Rovai, Rubino, Samaha, Samalin, Sugawara, Szkultecka-Debek, Ventriglio, Volkow   +39 more
core   +4 more sources